Acet

Quick links to important sections

Acet

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Acet

Property Description
Active Ingredients Acetaminophen (Paracetamol), Cetirizine, Acetylcysteine
Form Tablet, Capsule, Oral Solution (Oral administration)
Pharmacological Class Analgesic, Antipyretic, Antihistamine, and Mucolytic combination
Common Use Integrated symptomatic relief of pain, fever, allergy, and congestion
Origin Synthesized compounds

What is Acet and What Pharmacological Class Does it Belong To?

Acet is classified as a Fixed-Dose Combination (FDC) medicine, distinguishing it as a single oral preparation that systematically incorporates three distinct active ingredients for multi-action relief. Its high-level classification places it in the group of Analgesic, Antipyretic, Antihistamine, and Mucolytic combinations. The inclusion of Acetaminophen (Paracetamol) confirms its role as an analgesic and antipyretic agent, a therapeutic category noted for its use in managing mild to moderate pain.

What are the Active Ingredients in the Acet Formulation?

The Acet formulation is centered on the three primary International Nonproprietary Name (INN) drugs: Acetaminophen (Paracetamol), Cetirizine, and Acetylcysteine. Each compound contributes a specific and complementary action. Cetirizine is included to block histamine, a key mediator of allergic symptoms. Additionally, Acetylcysteine acts as a dedicated mucolytic agent, chemically reducing the viscosity of thick respiratory secretions. This combination is designed for patients experiencing symptoms that involve systemic discomfort alongside specific allergic and respiratory congestion components.

What is the General Purpose of This Combination Medicine?

The general purpose of Acet is to offer integrated symptomatic relief by simultaneously targeting the pathways responsible for multiple concurrent discomforts. By combining agents that reduce pain and fever with those that counter allergic responses and thin respiratory mucus, the product provides a single strategy to mitigate discomfort and support general well-being during acute illness, such as those associated with severe seasonal allergies and common respiratory infections.

Regulatory References

  1. Cetirizine: MedlinePlus Drug Information

What side effects are possible with Acet?

Possible Side Effects and Safety Information

The official safety profile for the combination medicine Acet (Acetaminophen, Cetirizine, Acetylcysteine) describes adverse reactions classified by frequency and the body systems they affect, according to regulatory standards.

Frequency-Classified Adverse Reactions

The most frequently documented effects, classified as Common in official labeling, include somnolence (drowsiness), fatigue, dry mouth, nausea, and pharyngitis. Reactions classified as Uncommon include headache, diarrhea, abdominal pain, pruritus (itching), and skin rash. Rare or Very Rare events documented in regulatory sources include severe skin reactions (such as Stevens-Johnson syndrome) and anaphylactic shock.

Serious Adverse Reactions and Constraints

The most significant safety constraint is the mandated regulatory warning concerning the risk of hepatotoxicity (acute liver failure), which is associated with the acetaminophen component. This risk is explicitly linked to use that exceeds the maximum recommended daily dosage from all sources. The medicine is contraindicated in individuals with severe hepatic impairment or severe active liver disease. The label also documents severe hypersensitivity reactions, including anaphylaxis and angioedema.

Population-Specific Safety Notes

Safety constraints apply to specific populations; for instance, patients with decreased renal function may require adjustment for one component. Due to the presence of the antihistamine, the combination may cause additive impairment of mental alertness when used concurrently with alcohol or other central nervous system depressants. These classifications reflect how government regulatory documents organize and communicate the medicine’s safety profile.

Overdose and Emergency Response

Overdose and when to seek help

Overdose with this medicine requires immediate medical attention or that medical help be sought right away, regardless of whether symptoms are currently present. Contacting emergency services or a local Poison Help center is officially mandated for suspected overdosage.

Documented Manifestations and Severe Outcomes The most critical documented risk is severe liver damage associated with the acetaminophen component, which can progress to hepatic necrosis, liver failure, and death. Early manifestations of overexposure include non-specific signs such as nausea, vomiting, diaphoresis (sweating), pallor, and general malaise. Delayed signs of progressive organ injury include upper quadrant abdominal pain, jaundice, and confusion.

The antihistamine component, Cetirizine, may contribute to clinical manifestations such as somnolence, restlessness, tachycardia, and urinary retention.

Required Emergency Actions N-Acetylcysteine (NAC) is the specific antidote for acetaminophen toxicity and must be instituted immediately in cases of known or suspected overdosage. Treatment protocols, as defined by regulatory authorities, focus on symptomatic and supportive treatment, including necessary laboratory monitoring. Required monitoring involves obtaining plasma acetaminophen concentration and testing for hepatic enzyme levels and coagulation defects. Furthermore, the label notes increased risk of severe toxicity in populations with underlying conditions such as hepatic impairment, alcoholism, or chronic malnutrition.

Therapeutic Uses of Acet

What Acet Treats: Main Uses and Benefits

The Acet combination is applied across specific therapeutic domains to provide comprehensive, supportive relief for concurrent symptoms associated with acute illness and allergic episodes. Acetaminophen, a core component, is commonly used in the management of fever and pain.

This medication is relevant for conditions characterized by periods of heightened symptoms, including the common cold, flu-like illness, and allergic rhinitis. It helps address symptom clusters that include mild to moderate pain, fever, sneezing, runny nose, and thick, viscous sputum.

It is commonly used when symptoms cluster into patterns requiring supportive management. It is applied in clinical settings that involve acute or unstable symptom patterns. It is helpful in situations where multiple symptoms occur together. The combination provides support that helps ease the overall symptom load during multi-faceted episodes.


Quick Facts: Therapeutic Focus

  • Systemic Discomfort: Used for managing symptoms related to physical discomfort and systemic imbalance, such as pain and elevated body temperature.
  • Respiratory & Allergic Relief: Applied when symptoms relate to inflammatory or irritative states, including allergic manifestations and mucus-related cough.

Regulatory References

  1. Health Canada symptomatic care guidance

Eligibility and Restrictions for Use

Who Can and Cannot Use Acet?

The population eligibility for the fixed-dose combination (FDC) Acet (Acetaminophen, Cetirizine, Acetylcysteine) is determined by official regulatory documents based on organ function, age, and prior medical history.

Contraindications and Restrictions

Category Eligibility Rule (Official Labeling)
Absolute Contraindication The medicine is contraindicated in patients with severe active liver disease or severe hepatic impairment due to the Acetaminophen component. It is also contraindicated in patients with End-Stage Renal Disease (requiring dialysis) and those with known hypersensitivity to any component.
Usage Prohibition Must not be used concurrently with any other product containing Acetaminophen.

Age- and Condition-Based Eligibility

Use is generally approved for Adults and Adolescents over 12 years of age. Use in Children under 6 years is typically not recommended by regulatory agencies for this FDC category. Caution is advised for patients with non-severe impaired renal or impaired hepatic function, and dose adjustments may be warranted. Use during pregnancy and lactation is generally not recommended or advised only if clearly needed, as the safety of the combination is not fully established in these populations. Individuals with chronic alcohol abuse or chronic malnutrition should use the medicine with caution.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation structures the interaction profile of Acet (Acetaminophen, Cetirizine, Acetylcysteine) around specific pharmacologic and metabolic constraints.

Contraindicated Combinations

Co-administration with other Acetaminophen-containing products is formally contraindicated due to the severe risk of exceeding the total daily dose, which is documented to cause acute liver failure.


Documented Interaction Categories

Interaction Type Interacting Substance / Category Official Outcome Description
Hepatotoxicity Risk Chronic, Excessive Alcohol Induces hepatic enzymes, increasing the production of toxic Acetaminophen metabolites.
Pharmacodynamic CNS Depressants (e.g., Opioids, other Antihistamines) Causes additive sedation and impairment of performance due to the Cetirizine component.
Exposure Modification Warfarin / Anticoagulants May result in an increase in the International Normalized Ratio (INR), reflecting enhanced anticoagulant effect.
Exposure Modification Theophylline (high dose) Documented to decrease the clearance of Cetirizine.
Pharmacodynamic Nitroglycerin Acetylcysteine component potentiates the vasodilatory and hypotensive effects.

Population-Specific Interaction Notes

Patients with severe active liver disease or hepatic impairment are at increased risk of toxicity from the Acetaminophen component. Similarly, renal impairment may alter the clearance of Cetirizine, potentially leading to greater risk of adverse effects, a factor noted in regulatory labeling. The consumption of alcohol is strongly advised against due to the combined risk of severe hepatic toxicity and additive CNS depression.

Mechanism of Action

How Acetaminophen Works: Mechanism of Action

Central Inhibition of COX and Prostaglandin Synthesis

Acetaminophen's primary mechanism involves interfering with the Cyclooxygenase (COX) enzymes located predominantly in the Central Nervous System (CNS), particularly by acting as a reducing co-substrate at the enzyme's peroxidase site. This action decreases the synthesis of Prostaglandin E2 ( PGE2) in the brain's temperature-regulating center (hypothalamus), which is the molecular basis for a shift in the body's thermoregulatory set point.

Dual-Action Mechanism via Descending Pain Pathways

The mechanism that elevates the pain threshold involves two combined actions: the reduced central PGE2 synthesis and the influence of a key metabolite, AM404. This metabolite modulates receptors involved in pain, including TRPV1 receptors, and indirectly influences the endocannabinoid system. This modulation leads to an elevation of the central pain threshold by influencing the activity of the body's descending inhibitory pain signals.

Dosage and Administration Information

The use of Acet is governed by administration guidelines that standardize its intake and scheduling, reflecting requirements for its three active components. The medicine is consistently prescribed for oral administration across all approved dosage forms, including the tablet, capsule, and oral solution.

Official Administration Scope

Feature Detail
Route of administration: Oral use only.
Dosing schedule: The Maximum Total Daily Dose of the Acetaminophen component is restricted to 4000 mg in adults.
Frequency and timing: Administration requires a minimum interval of 4 hours between doses to prevent component accumulation.
Special procedural condition: Patients must account for Acetaminophen intake from all other sources to ensure the daily limit is not exceeded.

Required Adjustments and Use Context

Dosing frequency or amount must be modified for certain populations. Dose reduction is a required procedural step for patients with hepatic impairment (due to the Acetaminophen component) and those with renal impairment (due to the Cetirizine component). Furthermore, administration is designated for short-term use only, limited strictly to the duration of the acute symptom phase for which it is intended.

Connection to the Overall Use Protocol

The entire protocol is structured to ensure that the necessary time spacing and dose restrictions are followed. The minimum dosing interval and the strict daily maximum define the allowable frequency and amount of medicine that can be administered in a 24-hour period. These administration guidelines define the standardized use of the drug.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Acet

This overview summarizes the structure of the official research, primarily drawing from Randomized Controlled Trials (RCTs) and scientific reviews, that was studied for the components of Acet. It outlines what researchers examined, the patterns observed in the studies so far, and what aspects of the combination remain unclear according to the scientific literature.


Evidence for Symptomatic Relief of Acute Viral Illness

The research relevant to symptomatic relief during common cold or flu-like discomfort includes evidence from short-term RCTs and aggregated meta-analyses that research examined the pain and fever-reducing component, Acetaminophen. These studies were used in research exploring how symptoms change over time in conditions associated with acute or disruptive episodes, such as headache, muscle aches, and outcomes related to systemic or functional imbalance, specifically measured body temperature.

The research generally describes patterns of measured change in symptom intensity, with findings from different studies focusing on the time it was observed in that symptoms stabilized during the study period. What remains uncertain is the specific evidence for the exact three-drug combination in large-scale, long-duration trials. The follow-up durations were limited, typically lasting only a few days or up to one week, meaning that long-term effects are not fully established.


Evidence for Concurrent Allergic and Respiratory Symptoms

Research exploring the antihistamine component was studied for its role in conditions involving periods of heightened symptoms such as sneezing and a runny nose. RCTs and systematic reviews in allergic rhinitis applied in studies examining patient-reported experiences of outcomes linked to inflammatory or irritative states. The data show patterns related to symptom scores for allergic manifestations, with the strongest scientific literature generally supporting the antihistamine component’s evidence base in conditions like allergic rhinitis. However, the findings were mixed when assessing the precise role of all three components simultaneously in a patient experiencing both acute illness and an allergic episode.


Scientific Gaps and Research Uncertainty for Acet

Research on the mucolytic component (Acetylcysteine) was evaluated in studies research examining the physical consistency of respiratory mucus. Studies report how symptoms evolved in the observed populations, but the evidence is limited for its role in conditions associated with acute or disruptive episodes like the common cold, compared to its use in chronic conditions. This medicine's evidence often contributes to understanding symptom patterns based on the evidence base for the individual components, rather than research specifically on the precise three-way mixture. The evidence quality varies across studies, and comparative evidence is lacking for the specific three-drug FDC against other multi-component combinations used for the same general purposes.

Key Studies & References

  1. Common cold - Management Approach | BMJ Best Practice
  2. ACETYLCYSTEINE inhalant - DailyMed (FDA Labeling for Mucolytic Indication)

Frequently Asked Questions (FAQ)

Common questions about Acet (FAQ)

Q: How long does it typically take for Acet to start working?

Studies and official information indicate that the time it takes for the components to start working varies slightly. The pain-relief component, Acetaminophen, is typically absorbed and begins to act within 30 minutes to one hour after being taken orally. The antihistamine component, Cetirizine, is often noted to begin its effects within one hour of administration.

Q: Is Acet known to interact with common pain relievers?

Regulatory labeling formally contraindicates using Acet with any other product that contains Acetaminophen to prevent exceeding the recommended daily limit. However, separate studies on the Cetirizine component show no known drug interaction with non-acetaminophen pain relievers, such as Ibuprofen.

Q: How is Acet eliminated from the body?

The active components of this medicine are processed and removed by two primary organ systems. The Acetaminophen component is largely broken down (metabolized) by the liver. Both the metabolized Acetaminophen and the Cetirizine component are then primarily cleared from the body by the kidneys. This elimination process is why dose adjustments may be necessary for people with impaired liver or kidney function.

Q: Is Acet recommended for use during breastfeeding?

Official regulatory warnings state that use during lactation (breastfeeding) is generally not recommended. Regulatory guidance suggests that use is advised only when the potential benefit is considered to outweigh the risks. This is because official information indicates that components like Cetirizine are known to pass into breast milk, raising caution due to the potential for effects such as drowsiness in the infant.

Q: Does Acet interact with birth control pills?

Official information indicates that the Acetaminophen component may cause a decrease or delay in its own therapeutic effects when it is used concurrently with oral contraceptives containing Ethinyl Estradiol. However, regulatory documents state that concurrent use at usual therapeutic doses is generally not associated with a significant change in risk.

Q: Is Acet available in different strengths?

The medicine is described in official documents as being available in multiple dosage forms, including tablets, capsules, and oral solution. While the individual active ingredients may be available in various strengths, the Fixed-Dose Combination is typically supplied in standardized concentrations approved for its specific indications.

Q: How does Acet compare to a simple vitamin?

Acet is classified by regulatory authorities as a medicine belonging to the therapeutic categories of Analgesic, Antipyretic, Antihistamine, and Mucolytic. Vitamins are regulated differently as dietary supplements or essential nutrients and do not share the same pharmacological class or intended actions as this combination medicine.

Q: Is Acet the same kind of medicine as Advil or Tylenol?

Acet is a Fixed-Dose Combination medicine that contains Acetaminophen (which is the component found in Tylenol), Cetirizine, and Acetylcysteine. It is classified differently than Advil (Ibuprofen), which is a Non-Steroidal Anti-Inflammatory Drug (NSAID). Acet is not classified as an NSAID.

Q: Can Acet cause long-term health issues?

Regulatory documents explicitly state that administration is designated for short-term use only, strictly limited to the duration of the acute symptom phase. Furthermore, the scientific literature notes that the follow-up durations in research studies were typically limited, meaning that long-term effects of the combination are not fully established.

Q: Does Acet make you feel drowsy or sleepy?

Yes, official safety labeling classifies somnolence (drowsiness or sleepiness) and fatigue as commonly documented adverse reactions associated with the medicine. Because of this, official labeling describes the risk of impairment of mental alertness, and patients are typically advised to understand the medicine's effects before driving or operating machinery.

Q: Are there any specific foods or drinks to avoid while taking Acet?

Official labeling strongly advises against the consumption of alcohol due to the combined risk of severe hepatic toxicity and additive central nervous system (CNS) depression. Regulatory documents do not contain warnings regarding specific foods.

Q: What is the difference between Acet and a prescription drug for the same condition?

The distinction between prescription (Rx) and over-the-counter (OTC) status is determined by government agencies. Acet is regulated as an FDC with components that can be found in both prescription and OTC products. Prescription drugs require authorization from a healthcare provider, while OTC medicines do not.

Q: Is Acet safe for older adults?

Use is generally approved for adults. However, caution is advised for patients with certain impaired organ functions, such as renal or hepatic impairment, which are common considerations in older populations. Regulatory information notes that adjustment of the dose may be required in these specific patient groups.

Q: Does Acet affect blood pressure?

Studies on the Acetaminophen component indicate it may cause a small increase in blood pressure in individuals who already have high blood pressure when taken at maximum recommended doses. Separately, the Acetylcysteine component is noted to potentiate the hypotensive (blood pressure lowering) effects of the drug Nitroglycerin.

Q: Is Acet considered a high-alert medication?

Acet is not explicitly listed as a 'high-alert medication' in key safety organization documents. However, certain combination products containing the Acetaminophen component alongside an opioid are officially classified as high-alert due to the potential for serious harm if a mistake occurs.

Q: Can Acet affect my liver test results?

Yes, the Acetaminophen component has been described in studies to cause transient elevations in serum aminotransferase levels (which are liver enzymes) in a proportion of subjects, even when used at the maximum therapeutic dose over a period of time.

Q: Can Acet affect alertness for driving?

Yes, due to the presence of the antihistamine component, the combination may cause additive impairment of mental alertness, including drowsiness. Official labeling notes that the presence of the antihistamine component can cause impairment of mental alertness, and generally advises caution with activities like driving or operating machinery.

Q: What is the maximum number of days Acet is generally used for?

Official regulatory documents specify that administration is designated for short-term use only. This use is limited strictly to the duration of the acute symptom phase for which it is intended, and patients are generally advised to adhere to the short-term use designation.

Q: How is the safety of Acet monitored after it is approved?

The safety of the medicine is monitored after approval through official regulatory processes, including pharmacovigilance and post-marketing surveillance. This ongoing monitoring collects data on reported adverse reactions, including Rare or Very Rare events, to update and maintain the medicine’s official safety profile.

Q: Are there documented cases of Acet overdose?

Yes. The risk of hepatotoxicity (acute liver failure) is explicitly linked in regulatory warnings to use that exceeds the maximum recommended daily dosage, often due to accidental or intentional overdose. Severe liver injury, including cases of acute liver failure, has been reported in patients using this component.

Q: Can Acet be crushed or split?

The administration guidelines specify the drug's approved forms, such as tablet, capsule, and oral solution. Unless a specific form (like a scored tablet) is explicitly labeled by the manufacturer as being safe to split, regulatory standards generally indicate that tablets or capsules should be taken whole to preserve the intended stability and release of the medicine, unless the specific form is explicitly labeled otherwise.

Q: Why is it important to check the expiration date on Acet?

Expiration dates reflect the time period during which the product is known to retain its full strength, quality, and purity when it is stored according to its labeled conditions. Taking medicine that has degraded might result in a lower strength than intended, or its quality may be compromised.

Q: Is Acet a non-steroidal anti-inflammatory drug (NSAID)?

No. Acet is classified as an Analgesic, Antipyretic, Antihistamine, and Mucolytic combination. It is not classified as a Non-Steroidal Anti-Inflammatory Drug (NSAID), as its pain-relief component, Acetaminophen, does not share the significant peripheral anti-inflammatory effects characteristic of the NSAID drug class.

Q: Can Acet cause changes in mood or behavior?

The Cetirizine component is an antihistamine that affects the nervous system. The use of nervous system depressants, which can include antihistamines, has been associated in some studies with reports of abnormal thinking and behavior changes.

Q: Are there reports of Acet causing dizziness?

Yes, dizziness is a documented adverse reaction associated with the antihistamine component, Cetirizine. Official information notes that this effect can be increased when the medicine is used concurrently with alcohol or other central nervous system depressants.

How should Acet be stored and disposed of?

How to Store and Dispose of Acetaminophen, Cetirizine, and Acetylcysteine

The storage and disposal of this medicine must comply strictly with the official regulatory labeling.


Storage Requirements

Condition Requirement
Temperature Store at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F), with permitted excursions.
Protection Keep the product protected from moisture and excessive heat. Do not freeze oral solutions.
Container Store in the original container, ensuring it remains tightly closed to maintain stability.
Child Safety Mandatory instruction to keep the medicine out of the sight and reach of children.

Disposal Instructions

Unused or expired Acet should be discarded following official guidelines. The preferred method is using a drug take-back program or authorized collection site. Alternatively, if a take-back program is unavailable, mix the medicine with an unappealing substance, place it in a sealed container, and dispose of it in the household trash; do not flush the product down the toilet or drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Acet found in:

A-Z Index: